First-in-Human trial launches for Custom-Built cancer treatment
NCT ID NCT07196579
Summary
This early-stage study is testing a new, personalized cell therapy called KXV01 for people with advanced solid tumors that have not responded to standard treatments. The therapy involves collecting a patient's own immune cells, genetically modifying them to better target their specific cancer, and then infusing them back. The main goals are to check the safety of different doses and see if the treatment shows any early signs of helping to control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.